Some molecular genetic features including IDH1/2 mutation, MGMT promotor methylation, codeletion of 1p/19q, TERT loss, and ATRX mutation have been reported to be associated with favorable prognosis in gliomas [14, 15]. The gene discussed is TERT; the disease is central nervous system cancer.